New Sexual Health & HIV Policy EUROBulletin

Greta Hughson
Published: 26 April 2017

This week we published our first edition of the Sexual Health & HIV Policy EUROBulletin – it’s a free, quarterly email newsletter, so do sign up to receive future editions.

Building on strong foundations

Although it’s the first edition we’ve published, it’s actually issue number 8. The bulletin was previously published by MEDFASH, and NAM has taken on the bulletin since MEDFASH’s closure at the end of 2016. We would really like to thank our friends at MEDFASH for all their work in creating the bulletin.

The EUROBulletin aims to provide information about policies, programmes, standards, guidance, evidence and research, and emerging issues in sexual and reproductive healthcare, HIV treatment and care, prevention and sexual health promotion in Europe. We’ll be seeking out interesting new information in these areas to share.

The eFeature

Each bulletin will also include an interview, and in the April edition we were fortunate to have the opportunity to talk to Dr Manjulaa Narasimhan from the World Health Organization (WHO). Manjulaa is the lead technical officer for WHO’s new Consolidated guideline on sexual and reproductive health and rights of women living with HIV. The process for creating the new guideline was unusual in its strong focus on including the voices and opinions of women throughout, including starting with a global community survey led by women living with HIV. You can read Manjulaa’s eFeature on the NAM blog.

Sign up, share, get in touch!

If you’re not already on the mailing list, then do sign up to receive future editions of this bulletin.

We’d also be delighted if you would share the bulletin and the sign-up page with your networks.

We’d love to hear from you if you have feedback on this edition, ideas for future editions, or news to share, so please do get in touch.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.